ID   KH-39
AC   CVCL_W214
SY   KH39
DR   Cosmic; 845929
DR   Wikidata; Q54899851
RX   PubMed=7154478;
RX   PubMed=8621251;
RX   PubMed=10723130;
RX   PubMed=10929426;
RX   PubMed=27993170;
CC   Population: Japanese.
CC   Doubling time: 16.0 hours (PubMed=7154478).
CC   Misspelling: KN-39; Note=Occasionally.
CC   Misspelling: KN39; Note=Occasionally.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
RX   PubMed=7154478; DOI=10.5980/jpnjurol1928.73.8_1019;
RA   Naito K., Hisazumi H., Kanokogi M., Katoh M., Nakazima K.,
RA   Tsukahara K., Kobayashi T., Kuroda K., Matsubara F.;
RT   "Establishment of cell lines (KH-39, KN-41, and KW-103) from human
RT   kidney and bladder cancer and their characteristics.";
RL   Nihon Hinyokika Gakkai Zasshi 73:1019-1031(1982).
//
RX   PubMed=8621251; DOI=10.1002/(SICI)1097-0215(19960503)66:3<322::AID-IJC9>3.0.CO;2-0;
RA   Tomita Y., Bilim V., Kawasaki T., Takahashi K., Okan I.,
RA   Magnusson K.P., Wiman K.G.;
RT   "Frequent expression of Bcl-2 in renal-cell carcinomas carrying
RT   wild-type p53.";
RL   Int. J. Cancer 66:322-325(1996).
//
RX   PubMed=10723130; DOI=10.1038/sj.onc.1203449;
RA   Alimov A., Kost-Alimova M., Liu J., Li C.-D., Bergerheim U.S.R.,
RA   Imreh S., Klein G., Zabarovsky E.R.;
RT   "Combined LOH/CGH analysis proves the existence of interstitial 3p
RT   deletions in renal cell carcinoma.";
RL   Oncogene 19:1392-1399(2000).
//
RX   PubMed=10929426; DOI=10.1007/s002400000103;
RA   Shintaku I., Kawagoe N., Yutani S., Hoshi S., Orikasa S.,
RA   Yoshizumi O., Itoh K.;
RT   "Expression of the SART1 tumor rejection antigen in renal cell
RT   carcinoma.";
RL   Urol. Res. 28:178-184(2000).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8; PMCID=PMC5168717;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//